Logo image of CTM

CASTELLUM INC (CTM) Stock Fundamental Analysis

NYSEARCA:CTM - US14838T2042 - Common Stock

1.02 USD
-0.01 (-0.97%)
Last: 8/25/2025, 8:12:50 PM
1.02 USD
0 (0%)
After Hours: 8/25/2025, 8:12:50 PM
Fundamental Rating

3

Taking everything into account, CTM scores 3 out of 10 in our fundamental rating. CTM was compared to 83 industry peers in the IT Services industry. The financial health of CTM is average, but there are quite some concerns on its profitability. CTM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CTM had negative earnings in the past year.
CTM had a negative operating cash flow in the past year.
CTM had negative earnings in each of the past 5 years.
In multiple years CTM reported negative operating cash flow during the last 5 years.
CTM Yearly Net Income VS EBIT VS OCF VS FCFCTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

CTM has a Return On Assets of -12.95%. This is in the lower half of the industry: CTM underperforms 79.52% of its industry peers.
CTM has a worse Return On Equity (-17.71%) than 65.06% of its industry peers.
Industry RankSector Rank
ROA -12.95%
ROE -17.71%
ROIC N/A
ROA(3y)-43.88%
ROA(5y)-36.34%
ROE(3y)-91.34%
ROE(5y)-85.43%
ROIC(3y)N/A
ROIC(5y)N/A
CTM Yearly ROA, ROE, ROICCTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of CTM (39.27%) is better than 60.24% of its industry peers.
CTM's Gross Margin has declined in the last couple of years.
CTM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.61%
GM growth 5YN/A
CTM Yearly Profit, Operating, Gross MarginsCTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

CTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CTM has been increased compared to 1 year ago.
The debt/assets ratio for CTM has been reduced compared to a year ago.
CTM Yearly Shares OutstandingCTM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
CTM Yearly Total Debt VS Total AssetsCTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

CTM has an Altman-Z score of 4.36. This indicates that CTM is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.36, CTM is doing good in the industry, outperforming 68.67% of the companies in the same industry.
A Debt/Equity ratio of 0.13 indicates that CTM is not too dependend on debt financing.
CTM has a better Debt to Equity ratio (0.13) than 68.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 4.36
ROIC/WACCN/A
WACC9.47%
CTM Yearly LT Debt VS Equity VS FCFCTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 3.62 indicates that CTM has no problem at all paying its short term obligations.
CTM has a better Current ratio (3.62) than 85.54% of its industry peers.
A Quick Ratio of 3.62 indicates that CTM has no problem at all paying its short term obligations.
CTM has a better Quick ratio (3.62) than 85.54% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.62
CTM Yearly Current Assets VS Current LiabilitesCTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

CTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.63%, which is quite impressive.
The Revenue has been growing slightly by 4.17% in the past year.
CTM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.32% yearly.
EPS 1Y (TTM)73.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.8%
Revenue 1Y (TTM)4.17%
Revenue growth 3Y21.32%
Revenue growth 5YN/A
Sales Q2Q%21.71%

3.2 Future

CTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.77% yearly.
Based on estimates for the next years, CTM will show a decrease in Revenue. The Revenue will decrease by -1.20% on average per year.
EPS Next Y112.5%
EPS Next 2Y45.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.86%
Revenue Next 2Y-1.2%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTM Yearly Revenue VS EstimatesCTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
CTM Yearly EPS VS EstimatesCTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 -0.05 -0.1 -0.15 -0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CTM is valuated quite expensively with a Price/Forward Earnings ratio of 100.99.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CTM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, CTM is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 100.99
CTM Price Earnings VS Forward Price EarningsCTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTM Per share dataCTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

CTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTM's earnings are expected to grow with 45.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.77%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTELLUM INC

NYSEARCA:CTM (8/25/2025, 8:12:50 PM)

After market: 1.02 0 (0%)

1.02

-0.01 (-0.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-08 2025-08-08/amc
Earnings (Next)11-11 2025-11-11
Inst Owners3.86%
Inst Owner Change108.11%
Ins Owners11.74%
Ins Owner Change-12.13%
Market Cap94.86M
Analysts80
Price Target3.06 (200%)
Short Float %2.19%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-3.38%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 100.99
P/S 1.99
P/FCF N/A
P/OCF N/A
P/B 2.99
P/tB 6.32
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)0.01
Fwd EY0.99%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.51
BVpS0.34
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.95%
ROE -17.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.27%
FCFM N/A
ROA(3y)-43.88%
ROA(5y)-36.34%
ROE(3y)-91.34%
ROE(5y)-85.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.61%
GM growth 5YN/A
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.57%
Cap/Sales 0.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.62
Altman-Z 4.36
F-Score4
WACC9.47%
ROIC/WACCN/A
Cap/Depr(3y)1.76%
Cap/Depr(5y)1.22%
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.8%
EPS Next Y112.5%
EPS Next 2Y45.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.17%
Revenue growth 3Y21.32%
Revenue growth 5YN/A
Sales Q2Q%21.71%
Revenue Next Year-5.86%
Revenue Next 2Y-1.2%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year167.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.46%
OCF growth 3YN/A
OCF growth 5YN/A